Goldman Sachs Knock-Out BAX/ DE000GG85YD4 /
02/08/2024 21:44:29 | Chg.-0.030 | Bid22:00:36 | Ask22:00:36 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.320EUR | -8.57% | - Bid Size: - |
- Ask Size: - |
Baxter International... | 32.2085 USD | 31/12/2078 | Call |
GlobeNewswire
26/06
Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
GlobeNewswire
20/06
ProvisionAi COO Terri Bennett Robbins Named One of 20 Women Reshaping the Future of Logistics and th...
GlobeNewswire
20/06
E-fuels offer long-term solution to key energy transition transport sectors, but journey needs to st...
GlobeNewswire
14/06
CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payme...
GlobeNewswire
12/06
2024 RealTrends + Tom Ferry The Thousand List Recognizes 44 eXp Realty Agents and Teams
GlobeNewswire
12/06
2024 Report: LGBTQ+ Advertising Influential Over Brand Perceptions & Purchase Decisions
GlobeNewswire
04/06
Wood Mackenzie appoints Xizhou Zhou as new head of Power and Renewables Business
GlobeNewswire
16/05
US November election results could decelerate energy transition, with $1 trillion in energy investme...
GlobeNewswire
15/05
Investigation Alert Baxter International, Eagle Pharmaceuticals, BioXcel Therapeutics, and ImmunityB...